Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. | The company’s cobas ...
HIV, the incurable virus that can lead to AIDS if not treated, is most prevalent in Georgia, with 23.1 cases per 100,000 ...
The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...
The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and ...
Flare-ups of herpes occur when the virus becomes active after being dormant. Triggers for these outbreaks can include stress, ...
Newly-released health data shows a huge rise in cases of syphillis in the North East between 2022 and 2023. The region saw a ...
Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback